Skip to main content
Clinical Trials/NCT03616171
NCT03616171
Completed
Not Applicable

A Sleep Intervention (SLEEP-Extend) for Young Adults At-Risk for Type 2 Diabetes

Emory University2 sites in 1 country6 target enrollmentAugust 30, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus, Type 2
Sponsor
Emory University
Enrollment
6
Locations
2
Primary Endpoint
Number of Enrollments in the Study Over One Year
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The study is a prospective unblinded randomized trial to evaluate the feasibility of conducting a sleep extension intervention trial and the sleep extension intervention among the young adults. The study also wants to assess whether a sleep-extension intervention has an impact on the insulin resistance levels of young adults. The intervention consists of an education session and to extend the sleep time at least one hour but can be up to 2 hours per night for 4 weeks.

Detailed Description

Insulin Resistance has been shown to put a person at risk for developing Type II diabetes. There is a correlation between sleep deprivation and insulin resistance.The study wants to assess the feasibility by enrolling 20 subjects in a year. The study also wants to assess the feasibility of the sleep extension intervention among young adults by examining the number of subjects that are randomized to intervention arm will complete the study. Another intent of the study is to examine how sleep behaviors affect risks for developing type 2 diabetes and to determine their willingness to participate in a 4-week home-based program (intervention) focused on personal sleep behaviors. Subjects enrolled in the study and are randomized to intervention group and control group. The intervention group will receive one education session consisting of strategies for sleep hygiene which is the routine for going to sleep and instructions on extending time in bed by at least one hour but can be up to 2 hours total per night for 4 weeks. At the end of 4 weeks subjects will have a blood draw and will complete the questionnaires.

Registry
clinicaltrials.gov
Start Date
August 30, 2017
End Date
April 2, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ashley Coombe

Assistant Professor

Emory University

Eligibility Criteria

Inclusion Criteria

  • Age must be 18-25 years old
  • Self-report short sleep
  • BMI ≥ 30 (the World Health Organization's classification of being obese)
  • Insulin Resistance determined by serum analysis
  • Be willing to extend time in bed by one hour total per night
  • Read and speak English.

Exclusion Criteria

  • Night shift worker;
  • Sleep disorder diagnosis;
  • Medical diagnosis of diabetes or pre-diabetes;
  • Currently pregnant or lactating or with history of gestational diabetes;
  • Actively participating in a weight loss program;
  • Hospitalization in past 3 months for any medical or psychiatric condition;
  • Having a major chronic illness (e.g. cancer, Lupus)

Outcomes

Primary Outcomes

Number of Enrollments in the Study Over One Year

Time Frame: Up to 12 months

Feasibility of the study is assessed by number of enrollments in the study over a one year period. Study proposes to enroll minimum 20 subjects to meet the feasibility of the study.

Number of Participants Enrolled in the Intervention Arm Who Complete the Study

Time Frame: Week 4

Feasibility of the SLEEP-Extend intervention among young adults is measured by number of participants enrolled in the intervention arm that received the intervention and completed the study required protocols for the study duration of 4 weeks.

Secondary Outcomes

  • Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) Scores(Baseline, Week 4)
  • Hours of Sleep(Over a 1 week period at Baseline, and over a 1 week period at Week 4)
  • Number of Participants Extending Sleep(Over a 1 week period at Baseline, and over a 1 week period at Week 4)

Study Sites (2)

Loading locations...

Similar Trials